SCHEMBL7558089

SCHEMBL7558089

FC1c2ccccc2C(N2CCNCC2)c2ccc3c(c2C1Cl)C3

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TAAR1 Q96RJ0 1/20 0.34
FNTA P49354 1/20 0.34
FNTB P49356 1/20 0.34
ALDH1A1 P00352 1/20 0.31
MAPT P10636 1/20 0.31
THRB P10828 1/20 0.31
HPGD P15428 1/20 0.31
ALOX12 P18054 1/20 0.31
MAPK1 P28482 1/20 0.31
SMN1; SMN2 Q16637 1/20 0.31
NPSR1 Q6W5P4 1/20 0.31
USP2 O75604 1/20 0.31
GBA1 P04062 1/20 0.31
ALOX15 P16050 1/20 0.31
HK1 P19367 1/20 0.31
HKDC1 Q2TB90 1/20 0.31
DRD2 P14416 2/20 0.31
DRD1 P21728 2/20 0.31
DRD5 P21918 1/20 0.31
ADRA1D P25100 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8067630 0.90 TAAR1 (0.35) TAAR1FNTAFNTBALDH1A1MAPT
SCHEMBL7519877 0.89 TAAR1 (0.36) TAAR1FNTAFNTBALDH1A1MAPT
SCHEMBL7590047 0.83
SCHEMBL7557369 0.80 TAAR1 (0.35) TAAR1FNTAFNTBALDH1A1MAPT
SCHEMBL8964031 0.79 TAAR1 (0.37) TAAR1FNTAFNTBUSP2GBA1
SCHEMBL8068905 0.72 SMN1; SMN2 (0.30) MAPTSMN1; SMN2NPSR1
SCHEMBL8239748 0.69 TAAR1 (0.50) TAAR1FNTAFNTBHPGDSMN1; SMN2
SCHEMBL25579654 0.67 TAAR1 (0.44) TAAR1FNTAFNTBHPGDSMN1; SMN2
SCHEMBL8069075 0.67
SCHEMBL8067779 0.66 TAAR1 (0.42) TAAR1FNTAFNTBHPGDSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2002005818-A2 NOVEL METHOD OF USE OF MULTIDRUG RESISTANCE MODULATORS ELI LILLY AND COMPANY (US) 2002-01-24 WO disclosed
US-6087365-A TREATING DRUG-RESISTANT MALARIA IN A MAMMAL ELI LILLY AND COMPANY 2000-07-11 US disclosed
US-5889007-A CHEMISENSITIZING AGENTS; CANCER THERAPY DRUG RESISTANCE SYNTEX (U.S.A.) INC. (US) 1999-03-30 US disclosed
US-5874434-A SENSITIZERS FOR CANCER DRUGS SYNTEX (U.S.A.) INC. (US) 1999-02-23 US disclosed
EP-0695293-B1 10,11-METHANODIBENZOSUBERANE DERIVATIVES USED AS CHEMOSENSITIZING AGENTS SYNTEX INC (US) 1998-10-14 EP disclosed
EP-0866063-A1 10, 11-Methanodibenzosuberane derivatives used as chemosensitizing agents SYNTEX (U.S.A.) INC. (US) 1998-09-23 EP disclosed
US-5654304-A CHEMOSENSITIZING AGENTS; CANCER THERAPY; DRUG RESISTANCE SYNTEX (U.S.A.) INC. (US) 1997-08-05 US disclosed
US-5643909-A CHEMICAL SENSITIZERS FOR CANCER CHEMOTHERAPY FOR MULTIDRUG RESISTANCE SYNTEX (U.S.A.) INC. (US) 1997-07-01 US disclosed